Relief Therapeutics Holding SA (RLFTF)
| Previous Close | 1.3900 |
| Open | 1.2763 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.2400 - 1.4000 |
| 52 Week Range | 1.2000 - 8.4000 |
| Volume | |
| Avg. Volume | 2,550 |
| Market Cap | 17.106M |
| Beta (5Y Monthly) | -14.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.0400 |
| Earnings Date | Apr 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIRERelief Therapeutics has Published its Annual Report
GENEVA, SWITZARLAND / ACCESSWIRE / April 30, 2024 /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, ...
- ACCESSWIRE
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
Shareholders approved all proposals by a large majority GENEVA, SWITZERLAND / ACCESSWIRE / April 26, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF) (OTCQB:RLFTF, RLFTY) (Relief Therapeutics, or the Company), a biopharmaceutical company committed ...
- ACCESSWIRE
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
Relief Therapeutics Calls Extraordinary General MeetingAnticipated Board of Directors Overhaul GENEVA, SWITZERLAND / ACCESSWIRE / March 27, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics, or the Company), ...
